Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 342

1.

Interaction of ischaemic postconditioning and thrombectomy in patients with ST-elevation myocardial infarction.

Nepper-Christensen L, Høfsten DE, Helqvist S, Lassen JF, Tilsted HH, Holmvang L, Pedersen F, Joshi F, Sørensen R, Bang L, Bøtker HE, Terkelsen CJ, Maeng M, Jensen LO, Aarøe J, Kelbæk H, Køber L, Engstrøm T, Lønborg J.

Heart. 2019 Jul 17. pii: heartjnl-2019-314952. doi: 10.1136/heartjnl-2019-314952. [Epub ahead of print]

PMID:
31315939
2.

2-Year Clinical Outcomes of an Abluminal Groove-Filled Biodegradable-Polymer Sirolimus-Eluting Stent Compared With a Durable-Polymer Everolimus-Eluting Stent.

Xu B, Saito Y, Baumbach A, Kelbæk H, van Royen N, Zheng M, Morel MA, Knaapen P, Slagboom T, Johnson TW, Vlachojannis G, Arkenbout KE, Holmvang L, Janssens L, Ochala A, Brugaletta S, Naber CK, Anderson R, Rittger H, Berti S, Barbato E, Toth GG, Maillard L, Valina C, Buszman P, Thiele H, Schächinger V, Lansky A, Wijns W; TARGET AC Investigators.

JACC Cardiovasc Interv. 2019 May 22. pii: S1936-8798(19)31027-1. doi: 10.1016/j.jcin.2019.05.001. [Epub ahead of print]

PMID:
31129092
3.

Response by Kofoed et al to Letter Regarding Article, "Early Versus Standard Care Invasive Examination and Treatment of Patients With Non-ST-Segment Elevation Acute Coronary Syndrome: VERDICT Randomized Controlled Trial".

Kofoed KF, Kelbæk H, Engstrøm T, Køber LV.

Circulation. 2019 May 14;139(20):e961-e962. doi: 10.1161/CIRCULATIONAHA.119.040053. No abstract available.

PMID:
31082293
4.

Unreported exclusion and sampling bias in interpretation of randomized controlled trials in patients with STEMI.

Laursen PN, Holmvang L, Lønborg J, Køber L, Høfsten DE, Helqvist S, Clemmensen P, Kelbæk H, Jørgensen E, Lassen JF, Pedersen F, Høi-Hansen T, Raungaard B, Terkelsen CJ, Jensen LO, Sadjadieh G, Engstrøm T.

Int J Cardiol. 2019 Aug 15;289:1-5. doi: 10.1016/j.ijcard.2019.04.064. Epub 2019 May 1.

PMID:
31078351
5.

Impact of Multiple Myocardial Scars Detected by CMR in Patients Following STEMI.

Ekström K, Nepper-Christensen L, Ahtarovski KA, Kyhl K, Göransson C, Bertelsen L, Ghotbi AA, Kelbæk H, Helqvist S, Høfsten DE, Køber L, Schoos MM, Vejlstrup N, Lønborg J, Engstrøm T.

JACC Cardiovasc Imaging. 2019 Apr 10. pii: S1936-878X(19)30241-4. doi: 10.1016/j.jcmg.2019.01.032. [Epub ahead of print]

PMID:
31005537
6.

Complete Revascularization Versus Culprit Lesion Only in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease: A DANAMI-3-PRIMULTI Cardiac Magnetic Resonance Substudy.

Kyhl K, Ahtarovski KA, Nepper-Christensen L, Ekström K, Ghotbi AA, Schoos M, Göransson C, Bertelsen L, Helqvist S, Holmvang L, Jørgensen E, Pedersen F, Saunamäki K, Clemmensen P, De Backer O, Høfsten DE, Køber L, Kelbæk H, Vejlstrup N, Lønborg J, Engstrøm T.

JACC Cardiovasc Interv. 2019 Apr 22;12(8):721-730. doi: 10.1016/j.jcin.2019.01.248.

PMID:
31000010
7.

Five-year clinical outcomes and intracoronary imaging findings of the COMFORTABLE AMI trial: randomized comparison of biodegradable polymer-based biolimus-eluting stents with bare-metal stents in patients with acute ST-segment elevation myocardial infarction.

Räber L, Yamaji K, Kelbæk H, Engstrøm T, Baumbach A, Roffi M, von Birgelen C, Taniwaki M, Moschovitis A, Zaugg S, Ostojic M, Pedrazzini G, Karagiannis-Voules DA, Lüscher TF, Kornowski R, Tüller D, Vukcevic V, Heg D, Windecker S.

Eur Heart J. 2019 Jun 21;40(24):1909-1919. doi: 10.1093/eurheartj/ehz074.

PMID:
30851032
8.

Characterisation of lesions undergoing ischaemia-driven revascularisation after complete revascularisation versus culprit lesion only in patients with STEMI and multivessel disease: a DANAMI-3-PRIMULTI substudy.

De Backer O, Lønborg J, Helqvist S, Warnøe J, Kløvgaard L, Holmvang L, Pedersen F, Tilsted HH, Raungaard B, Jørgensen E, Køber L, Høfsten DE, Kelbæk H, Engstrøm T.

EuroIntervention. 2019 Jun 20;15(2):172-179. doi: 10.4244/EIJ-D-18-00766.

9.

Fractional flow reserve-guided percutaneous coronary intervention vs. medical therapy for patients with stable coronary lesions: meta-analysis of individual patient data.

Zimmermann FM, Omerovic E, Fournier S, Kelbæk H, Johnson NP, Rothenbühler M, Xaplanteris P, Abdel-Wahab M, Barbato E, Høfsten DE, Tonino PAL, Boxma-de Klerk BM, Fearon WF, Køber L, Smits PC, De Bruyne B, Pijls NHJ, Jüni P, Engstrøm T.

Eur Heart J. 2019 Jan 7;40(2):180-186. doi: 10.1093/eurheartj/ehy812.

10.

Early Versus Standard Care Invasive Examination and Treatment of Patients With Non-ST-Segment Elevation Acute Coronary Syndrome.

Kofoed KF, Kelbæk H, Hansen PR, Torp-Pedersen C, Høfsten D, Kløvgaard L, Holmvang L, Helqvist S, Jørgensen E, Galatius S, Pedersen F, Bang L, Saunamaki K, Clemmensen P, Linde JJ, Heitmann M, Wendelboe Nielsen O, Raymond IE, Kristiansen OP, Svendsen IH, Bech J, Dominguez Vall-Lamora MH, Kragelund C, Hansen TF, Dahlgaard Hove J, Jørgensen T, Fornitz GG, Steffensen R, Jurlander B, Abdulla J, Lyngbæk S, Elming H, Therkelsen SK, Abildgaard U, Jensen JS, Gislason G, Køber LV, Engstrøm T.

Circulation. 2018 Dec 11;138(24):2741-2750. doi: 10.1161/CIRCULATIONAHA.118.037152. Erratum in: Circulation. 2018 Dec 11;138(24):e750.

PMID:
30565996
11.

Changes in Coronary Plaque Composition in Patients With Acute Myocardial Infarction Treated With High-Intensity Statin Therapy (IBIS-4): A Serial Optical Coherence Tomography Study.

Räber L, Koskinas KC, Yamaji K, Taniwaki M, Roffi M, Holmvang L, Garcia Garcia HM, Zanchin T, Maldonado R, Moschovitis A, Pedrazzini G, Zaugg S, Dijkstra J, Matter CM, Serruys PW, Lüscher TF, Kelbaek H, Karagiannis A, Radu MD, Windecker S.

JACC Cardiovasc Imaging. 2019 Aug;12(8 Pt 1):1518-1528. doi: 10.1016/j.jcmg.2018.08.024. Epub 2018 Dec 12.

PMID:
30553686
12.

Deferred vs Immediate Stenting in Primary Percutaneous Coronary Intervention: A Collaborative Meta-analysis of Randomized Trials With Cardiac Magnetic Resonance Imaging Data.

Cassese S, Belle L, Ndrepepa G, Bosson JL, Fusaro M, Lønborg J, Ahtarovski KA, Kelbæk H, Fusaro M.

Can J Cardiol. 2018 Dec;34(12):1573-1580. doi: 10.1016/j.cjca.2018.07.480. Epub 2018 Aug 7.

PMID:
30527145
13.

Benefit From Reperfusion With Primary Percutaneous Coronary Intervention Beyond 12 Hours of Symptom Duration in Patients With ST-Segment-Elevation Myocardial Infarction.

Nepper-Christensen L, Lønborg J, Høfsten DE, Ahtarovski KA, Bang LE, Helqvist S, Kyhl K, Køber L, Kelbæk H, Vejlstrup N, Holmvang L, Engstrøm T.

Circ Cardiovasc Interv. 2018 Sep;11(9):e006842. doi: 10.1161/CIRCINTERVENTIONS.118.006842.

PMID:
30354595
14.

Relationship between patient presentation and morphology of coronary atherosclerosis by quantitative multidetector computed tomography.

de Knegt MC, Linde JJ, Fuchs A, Pham MHC, Jensen AK, Nordestgaard BG, Kelbæk H, Køber LV, Heitmann M, Fornitz G, Hove JD, Kofoed KF; CGPS, the CATCH, and the VERDICT Investigators .

Eur Heart J Cardiovasc Imaging. 2018 Oct 15. doi: 10.1093/ehjci/jey146. [Epub ahead of print]

PMID:
30325406
15.

Prognostic Value of the Residual SYNTAX Score After Functionally Complete Revascularization in ACS.

Kobayashi Y, Lønborg J, Jong A, Nishi T, De Bruyne B, Høfsten DE, Kelbæk H, Layland J, Nam CW, Pijls NHJ, Tonino PAL, Warnøe J, Oldroyd KG, Berry C, Engstrøm T, Fearon WF; DANAMI-3-PRIMULTI, FAME, and FAMOUS-NSTEMI Study Investigators.

J Am Coll Cardiol. 2018 Sep 18;72(12):1321-1329. doi: 10.1016/j.jacc.2018.06.069.

PMID:
30213322
16.

Targeted therapy with a localised abluminal groove, low-dose sirolimus-eluting, biodegradable polymer coronary stent (TARGET All Comers): a multicentre, open-label, randomised non-inferiority trial.

Lansky A, Wijns W, Xu B, Kelbæk H, van Royen N, Zheng M, Morel MA, Knaapen P, Slagboom T, Johnson TW, Vlachojannis G, Arkenbout KE, Holmvang L, Janssens L, Ochala A, Brugaletta S, Naber CK, Anderson R, Rittger H, Berti S, Barbato E, Toth GG, Maillard L, Valina C, Buszman P, Thiele H, Schächinger V, Baumbach A; TARGET All Comers Investigators.

Lancet. 2018 Sep 29;392(10153):1117-1126. doi: 10.1016/S0140-6736(18)31649-0. Epub 2018 Sep 3.

PMID:
30190206
17.

Importance of elevated heart rate in the very early phase of ST-segment elevation myocardial infarction: Results from the DANAMI-3 trial.

Nepper-Christensen L, Lønborg J, Ahtarovski KA, Høfsten DE, Kyhl K, Schoos MM, Göransson C, Laursen PN, Sadjadieh G, Ghotbi AA, Bertelsen L, Køber L, Helqvist S, Pedersen F, Jørgensen E, Kelbæk H, Vejlstrup N, Holmvang L, Engstrøm T.

Eur Heart J Acute Cardiovasc Care. 2019 Jun;8(4):318-328. doi: 10.1177/2048872618795515. Epub 2018 Aug 23.

PMID:
30136597
18.

Bleeding Events After ST-segment Elevation Myocardial Infarction in Patients Randomized to an All-comer Clinical Trial Compared With Unselected Patients.

Sadjadieh G, Engstrøm T, Høfsten DE, Helqvist S, Køber L, Pedersen F, Laursen PN, Andersson HB, Nepper-Christensen L, Clemmensen P, Sørensen R, Jørgensen E, Saunamäki K, Tilsted HH, Kelbæk H, Holmvang L.

Am J Cardiol. 2018 Oct 15;122(8):1287-1296. doi: 10.1016/j.amjcard.2018.07.008. Epub 2018 Jul 19.

PMID:
30115422
19.

Comparison between patients included in randomized controlled trials of ischemic heart disease and real-world data. A nationwide study.

Laursen PN, Holmvang L, Lønborg J, Køber L, Høfsten DE, Helqvist S, Clemmensen P, Kelbæk H, Jørgensen E, Lassen JF, Pedersen F, Høi-Hansen T, Therkelsen CJ, Tilsted HH, Jensen LO, Nepper-Christensen L, Sadjadieh G, Engstrøm T.

Am Heart J. 2018 Oct;204:128-138. doi: 10.1016/j.ahj.2018.05.018. Epub 2018 Aug 10.

PMID:
30103092
20.

Assessment of the myocardial area at risk: comparing T2-weighted cardiovascular magnetic resonance imaging with contrast-enhanced cine (CE-SSFP) imaging-a DANAMI3 substudy.

Göransson C, Ahtarovski KA, Kyhl K, Lønborg J, Nepper-Christensen L, Bertelsen L, Ghotbi AA, Schoos MM, Køber L, Høfsten D, Helqvist S, Kelbæk H, Engstrøm T, Vejlstrup N.

Eur Heart J Cardiovasc Imaging. 2019 Mar 1;20(3):361-366. doi: 10.1093/ehjci/jey106.

PMID:
30085055
21.

Ten-year clinical outcome of patients treated with a drug-eluting stent in the proximal left anterior descending artery segment compared with patients stented in other non-left main coronary segments.

Kjøller-Hansen L, Bligaard N, Kelbæk H, Christiansen EH, Thuesen L, Hansen PR, Engstrøm T, Junker A, Abildgaard U, Lassen JF, Jensen JS, Jeppesen JL, Galløe AM.

EuroIntervention. 2018 Sep 20;14(7):764-771. doi: 10.4244/EIJ-D-18-00396.

22.

Can copeptin and troponin T ratio predict final infarct size and myocardial salvage index in patients with ST-elevation myocardial infarction: A sub-study of the DANAMI-3 trial.

Árnadóttir Á, Schoos M, Lønborg J, Ahtarovski K, Kelbæk H, Helqvist S, Høfsten D, Clemmensen P, Engstrøm T, Nepper-Christensen L, Vejlstrup N, Køber L, Iversen K.

Clin Biochem. 2018 Sep;59:37-42. doi: 10.1016/j.clinbiochem.2018.06.012. Epub 2018 Jun 20.

PMID:
29932892
23.

MR-proADM as a Prognostic Marker in Patients With ST-Segment-Elevation Myocardial Infarction-DANAMI-3 (a Danish Study of Optimal Acute Treatment of Patients With STEMI) Substudy.

Falkentoft AC, Rørth R, Iversen K, Høfsten DE, Kelbæk H, Holmvang L, Frydland M, Schoos MM, Helqvist S, Axelsson A, Clemmensen P, Jørgensen E, Saunamäki K, Tilsted HH, Pedersen F, Torp-Pedersen C, Kofoed KF, Goetze JP, Engstrøm T, Køber L.

J Am Heart Assoc. 2018 May 18;7(11). pii: e008123. doi: 10.1161/JAHA.117.008123.

24.

Danegaptide for primary percutaneous coronary intervention in acute myocardial infarction patients: a phase 2 randomised clinical trial.

Engstrøm T, Nepper-Christensen L, Helqvist S, Kløvgaard L, Holmvang L, Jørgensen E, Pedersen F, Saunamaki K, Tilsted HH, Steensberg A, Fabricius S, Mouritzen U, Vejlstrup N, Ahtarovski KA, Göransson C, Bertelsen L, Kyhl K, Olivecrona G, Kelbæk H, Lassen JF, Køber L, Lønborg J.

Heart. 2018 Oct;104(19):1593-1599. doi: 10.1136/heartjnl-2017-312774. Epub 2018 Mar 30.

PMID:
29602883
25.

Relation of Bleeding Events to Mortality in Patients With ST-Segment Elevation Myocardial Infarction Treated by Percutaneous Coronary Intervention (a DANAMI-3 Substudy).

Sadjadieh G, Engstrøm T, Helqvist S, Høfsten DE, Køber L, Pedersen F, Laursen PN, Nepper-Christensen L, Clemmensen P, Møller-Helgestad OK, Sørensen R, Ravkilde J, Terkelsen CJ, Jørgensen E, Saunamäki K, Tilsted HH, Kelbæk H, Holmvang L.

Am J Cardiol. 2018 Apr 1;121(7):781-788. doi: 10.1016/j.amjcard.2017.12.019. Epub 2018 Jan 12.

PMID:
29402421
26.

Impact of diagnostic ECG-to-wire delay in STEMI patients treated with primary PCI: a DANAMI-3 substudy.

Nepper-Christensen L, Lønborg J, Høfsten DE, Ahtarovski KA, Kyhl K, Göransson C, Køber L, Helqvist S, Pedersen F, Kelbæk H, Vejlstrup N, Holmvang L, Engstrøm T.

EuroIntervention. 2018 Aug 20;14(6):700-707. doi: 10.4244/EIJ-D-17-00857.

27.

Value of Myocardial Perfusion Assessment With Coronary Computed Tomography Angiography in Patients With Recent Acute-Onset Chest Pain.

Sørgaard MH, Linde JJ, Kühl JT, Kelbæk H, Hove JD, Fornitz GG, Jørgensen TBS, Heitmann M, Kragelund C, Hansen TF, Abdulla J, Engstrøm T, Jensen JS, Wiegandt YT, Høfsten DE, Køber LV, Kofoed KF.

JACC Cardiovasc Imaging. 2018 Nov;11(11):1611-1621. doi: 10.1016/j.jcmg.2017.09.022. Epub 2017 Dec 13.

PMID:
29248654
28.

Reply: Deferred Stenting in STEMI: Still an Interest in Selected Patients?

Lønborg J, Engstrøm T, Kelbæk H.

J Am Coll Cardiol. 2017 Oct 31;70(18):2312. doi: 10.1016/j.jacc.2017.08.060. No abstract available.

29.

Longitudinal shortening of sub-epicardial myocytes in severe ischaemic cardiomyopathy: insights from gadolinium contrast cardiac magnetic resonance imaging.

Bjerre J, Kyhl K, Gustafsson F, Kelbaek H, Engstrøm T, Olsen PS, Hasbak P, Vejlstrup N, Madsen PL.

ESC Heart Fail. 2017 Nov;4(4):670-674. doi: 10.1002/ehf2.12187. Epub 2017 Oct 13.

30.

Long-term survival and causes of death in patients with ST-elevation acute coronary syndrome without obstructive coronary artery disease.

Andersson HB, Pedersen F, Engstrøm T, Helqvist S, Jensen MK, Jørgensen E, Kelbæk H, Räder SBEW, Saunamäki K, Bates E, Grande P, Holmvang L, Clemmensen P.

Eur Heart J. 2018 Jan 7;39(2):102-110. doi: 10.1093/eurheartj/ehx491.

PMID:
29029035
31.

Rehospitalizations Following Primary Percutaneous Coronary Intervention in Patients With ST-Elevation Myocardial Infarction: Results From a Multi-Center Randomized Trial.

Spitzer E, Frei M, Zaugg S, Hadorn S, Kelbaek H, Ostojic M, Baumbach A, Tüller D, Roffi M, Engstrom T, Pedrazzini G, Vukcevic V, Magro M, Kornowski R, Lüscher TF, von Birgelen C, Heg D, Windecker S, Räber L.

J Am Heart Assoc. 2017 Aug 5;6(8). pii: e005926. doi: 10.1161/JAHA.117.005926.

32.

Ischemic Postconditioning During Primary Percutaneous Coronary Intervention: Is Smoker's Paradox in Play?-Reply.

Engstrøm T, Høfsten DE, Kelbaek H.

JAMA Cardiol. 2017 Sep 1;2(9):1050. doi: 10.1001/jamacardio.2017.2481. No abstract available.

PMID:
28746722
33.

To defer, or not to defer, that is the question.

Kelbæk H, Høfsten DE, Engstrøm T.

EuroIntervention. 2017 Jul 20;13(4):381-382. doi: 10.4244/EIJV13I4A58. No abstract available.

34.

Myocardial Damage in Patients With Deferred Stenting After STEMI: A DANAMI-3-DEFER Substudy.

Lønborg J, Engstrøm T, Ahtarovski KA, Nepper-Christensen L, Helqvist S, Vejlstrup N, Kyhl K, Schoos MM, Ghotbi A, Göransson C, Bertelsen L, Holmvang L, Pedersen F, Jørgensen E, Saunamäki K, Clemmensen P, De Backer O, Kløvgaard L, Høfsten DE, Køber L, Kelbæk H; DANAMI-3 Investigators.

J Am Coll Cardiol. 2017 Jun 13;69(23):2794-2804. doi: 10.1016/j.jacc.2017.03.601.

35.

Complete versus culprit-only revascularisation in ST elevation myocardial infarction with multi-vessel disease.

Bravo CA, Hirji SA, Bhatt DL, Kataria R, Faxon DP, Ohman EM, Anderson KL, Sidi AI, Sketch MH Jr, Zarich SW, Osho AA, Gluud C, Kelbæk H, Engstrøm T, Høfsten DE, Brennan JM.

Cochrane Database Syst Rev. 2017 May 3;5:CD011986. doi: 10.1002/14651858.CD011986.pub2. Review.

36.

Fractional Flow Reserve-Guided Complete Revascularization Improves the Prognosis in Patients With ST-Segment-Elevation Myocardial Infarction and Severe Nonculprit Disease: A DANAMI 3-PRIMULTI Substudy (Primary PCI in Patients With ST-Elevation Myocardial Infarction and Multivessel Disease: Treatment of Culprit Lesion Only or Complete Revascularization).

Lønborg J, Engstrøm T, Kelbæk H, Helqvist S, Kløvgaard L, Holmvang L, Pedersen F, Jørgensen E, Saunamäki K, Clemmensen P, De Backer O, Ravkilde J, Tilsted HH, Villadsen AB, Aarøe J, Jensen SE, Raungaard B, Køber L, Høfsten DE; DANAMI 3-PRIMULTI Investigators.

Circ Cardiovasc Interv. 2017 Apr;10(4). pii: e004460. doi: 10.1161/CIRCINTERVENTIONS.116.004460.

PMID:
28404623
37.

Association Between Early Q Waves and Reperfusion Success in Patients With ST-Segment-Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention: A Cardiac Magnetic Resonance Imaging Study.

Topal DG, Lønborg J, Ahtarovski KA, Nepper-Christensen L, Helqvist S, Holmvang L, Pedersen F, Clemmensen P, Saünamaki K, Jørgensen E, Kyhl K, Ghotbi A, Schoos MM, Göransson C, Bertelsen L, Høfsten D, Køber L, Kelbæk H, Vejlstrup N, Engstrøm T.

Circ Cardiovasc Interv. 2017 Mar;10(3). pii: e004467. doi: 10.1161/CIRCINTERVENTIONS.116.004467.

PMID:
28264870
38.

Effect of Ischemic Postconditioning During Primary Percutaneous Coronary Intervention for Patients With ST-Segment Elevation Myocardial Infarction: A Randomized Clinical Trial.

Engstrøm T, Kelbæk H, Helqvist S, Høfsten DE, Kløvgaard L, Clemmensen P, Holmvang L, Jørgensen E, Pedersen F, Saunamaki K, Ravkilde J, Tilsted HH, Villadsen A, Aarøe J, Jensen SE, Raungaard B, Bøtker HE, Terkelsen CJ, Maeng M, Kaltoft A, Krusell LR, Jensen LO, Veien KT, Kofoed KF, Torp-Pedersen C, Kyhl K, Nepper-Christensen L, Treiman M, Vejlstrup N, Ahtarovski K, Lønborg J, Køber L; Third Danish Study of Optimal Acute Treatment of Patients With ST Elevation Myocardial Infarction–Ischemic Postconditioning (DANAMI-3–iPOST) Investigators.

JAMA Cardiol. 2017 May 1;2(5):490-497. doi: 10.1001/jamacardio.2017.0022.

39.

10-Year Clinical Outcome After Randomization to Treatment by Sirolimus- or Paclitaxel-Eluting Coronary Stents.

Galløe AM, Kelbæk H, Thuesen L, Hansen HS, Ravkilde J, Hansen PR, Christiansen EH, Abildgaard U, Stephansen G, Lassen JF, Engstrøm T, Jensen JS, Jeppesen JL, Bligaard N; SORT OUT II Investigators.

J Am Coll Cardiol. 2017 Feb 14;69(6):616-624. doi: 10.1016/j.jacc.2016.11.055.

40.

Drop-out from cardiovascular magnetic resonance in a randomized controlled trial of ST-elevation myocardial infarction does not cause selection bias on endpoints.

Laursen PN, Holmvang L, Kelbæk H, Vejlstrup N, Engstrøm T, Lønborg J.

Clin Res Cardiol. 2017 Jul;106(7):525-532. doi: 10.1007/s00392-017-1081-6. Epub 2017 Feb 6.

PMID:
28168513
41.

Left Ventricular Hypertrophy Is Associated With Increased Infarct Size and Decreased Myocardial Salvage in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.

Nepper-Christensen L, Lønborg J, Ahtarovski KA, Høfsten DE, Kyhl K, Ghotbi AA, Schoos MM, Göransson C, Bertelsen L, Køber L, Helqvist S, Pedersen F, Saünamaki K, Jørgensen E, Kelbæk H, Holmvang L, Vejlstrup N, Engstrøm T.

J Am Heart Assoc. 2017 Jan 9;6(1). pii: e004823. doi: 10.1161/JAHA.116.004823.

42.

Data on the quantitative assessment pulmonary ground-glass opacification from coronary computed tomography angiography datasets.

Kühl JT, Kristensen TS, Thomsen AF, Hindsø L, Hansen KL, Nielsen OW, Kelbæk H, Kofoed KF.

Data Brief. 2016 Nov 5;10:6-10. eCollection 2017 Feb.

43.

Bleeding episodes in "complete, staged" versus "culprit only" revascularisation in patients with multivessel disease and ST-segment elevation myocardial infarction: a DANAMI-3-PRIMULTI substudy.

Sadjadieh G, Engstrøm T, Helqvist S, Høfsten DE, Køber L, Pedersen F, Clemmensen P, Jørgensen E, Saunamäki K, Tilsted HH, Kelbæk H, Holmvang L.

EuroIntervention. 2016 Nov 20;12(10):1231-1238. doi: 10.4244/EIJV12I10A203.

44.

Subacute cardiac rubidium-82 positron emission tomography (82Rb-PET) to assess myocardial area at risk, final infarct size, and myocardial salvage after STEMI.

Ghotbi AA, Kjaer A, Nepper-Christensen L, Ahtarovski KA, Lønborg JT, Vejlstrup N, Kyhl K, Christensen TE, Engstrøm T, Kelbæk H, Holmvang L, Bang LE, Ripa RS, Hasbak P.

J Nucl Cardiol. 2018 Jun;25(3):970-981. doi: 10.1007/s12350-016-0694-x. Epub 2016 Oct 14.

45.

Prediction of clinical outcome by myocardial CT perfusion in patients with low-risk unstable angina pectoris.

Linde JJ, Sørgaard M, Kühl JT, Hove JD, Kelbæk H, Nielsen WB, Kofoed KF.

Int J Cardiovasc Imaging. 2017 Feb;33(2):261-270. doi: 10.1007/s10554-016-0994-x. Epub 2016 Oct 7.

PMID:
27718140
46.

Clinical and prognostic correlates of pulmonary congestion in coronary computed tomography angiography data sets.

Kühl JT, Kristensen TS, Thomsen AF, Hindsø L, Hansen KL, Nielsen OW, Kelbæk H, Kofoed KF.

J Cardiovasc Comput Tomogr. 2016 Nov - Dec;10(6):466-472. doi: 10.1016/j.jcct.2016.09.002. Epub 2016 Sep 15.

PMID:
27717753
47.

Deferred stenting in acute ST elevation myocardial infarction - Authors' reply.

Kelbæk H, Høfsten DE, Engstrøm T, Helqvist S, Køber L.

Lancet. 2016 Oct 1;388(10052):1371-1372. doi: 10.1016/S0140-6736(16)31466-0. No abstract available.

PMID:
27707487
48.

Myocardial perfusion 320-row multidetector computed tomography-guided treatment strategy for the clinical management of patients with recent acute-onset chest pain: Design of the CArdiac cT in the treatment of acute CHest pain (CATCH)-2 randomized controlled trial.

Sørgaard M, Linde JJ, Hove JD, Petersen JR, Jørgensen TB, Abdulla J, Heitmann M, Kragelund C, Hansen TF, Udholm PM, Pihl C, Kühl JT, Engstrøm T, Jensen JS, Høfsten DE, Kelbæk H, Kofoed KF.

Am Heart J. 2016 Sep;179:127-35. doi: 10.1016/j.ahj.2016.05.016. Epub 2016 Jun 18.

PMID:
27595687
49.

A post hoc analysis of long-term prognosis after exenatide treatment in patients with ST-segment elevation myocardial infarction.

Kyhl K, Lønborg J, Vejlstrup N, Kelbæk H, Helqvist S, Holmvang L, Jørgensen E, Saunamäki K, Bøtker HE, Clemmensen P, Køber L, Treiman M, Engstrøm T.

EuroIntervention. 2016 Jul 20;12(4):449-55. doi: 10.4244/EIJV12I4A78.

50.

Coronary CT angiography in clinical triage of patients at high risk of coronary artery disease.

Kühl JT, Hove JD, Kristensen TS, Norsk JB, Engstrøm T, Køber L, Kelbæk H, Kofoed KF.

Scand Cardiovasc J. 2017 Feb;51(1):28-34. doi: 10.1080/14017431.2016.1207799. Epub 2016 Aug 9.

PMID:
27366972

Supplemental Content

Loading ...
Support Center